Trial Profile
A Phase 2 Study for Transdermal Application of Teriparatide.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary) ; Teriparatide (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 29 Feb 2012 Actual end date (September 2011) added as reported by ClinicalTrials.gov.
- 29 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Aug 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.